Naproxen Sodium And Pseudoephedrine Hydrochloride Sinus And Headache Tablet, Extended Release
Product Images NDC 58602-832

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Naproxen Sodium And Pseudoephedrine Hydrochloride Sinus And Headache (NDC 58602-832). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurohealth Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Naproxen Figure (Naproxenpseudo Fig1)

Packaging label for Naproxen Sodium and Pseudoephedrine Hydrochloride Extended-Release Tablets, USP 220 mg/120 mg by Aurohealth LLC. The label highlights the product as a pain reliever/fever reducer (NSAID) and nasal decongestant, marketed under Sinus & Headache with 10 caplets (1 x 10's blister). It provides 12-hour multi-symptom relief and includes drug facts and warnings details on the carton.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.